Matches in Wikidata for { <http://www.wikidata.org/entity/Q92997836> ?p ?o ?g. }
Showing items 1 to 54 of
54
with 100 items per page.
- Q92997836 description "artículu científicu espublizáu n'avientu de 2019" @default.
- Q92997836 description "im Dezember 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92997836 description "scientific article published on 06 December 2019" @default.
- Q92997836 description "wetenschappelijk artikel" @default.
- Q92997836 description "наукова стаття, опублікована 6 грудня 2019" @default.
- Q92997836 name "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12" @default.
- Q92997836 name "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12" @default.
- Q92997836 type Item @default.
- Q92997836 label "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12" @default.
- Q92997836 label "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12" @default.
- Q92997836 prefLabel "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12" @default.
- Q92997836 prefLabel "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12" @default.
- Q92997836 P1433 Q92997836-AB9ACE12-5565-47F5-B84B-F7537984B8AD @default.
- Q92997836 P1476 Q92997836-D3CC96D5-5D85-49D6-B1A5-B53B7B5C3EA5 @default.
- Q92997836 P2093 Q92997836-0B50B42B-89A8-4066-8FAF-F030AFEC7FBD @default.
- Q92997836 P2093 Q92997836-13F643B4-F2E7-4055-B5C8-DAEE5B5C771D @default.
- Q92997836 P2093 Q92997836-25746FD3-523B-412F-9F70-3FF63234CE60 @default.
- Q92997836 P2093 Q92997836-2B5B1112-B3B7-419A-931E-A48DFAAD6AEF @default.
- Q92997836 P2093 Q92997836-3E957EDC-104A-40B0-B0ED-88C66634D646 @default.
- Q92997836 P2093 Q92997836-73EAE2D0-4CAD-4500-962E-42DDBC288E66 @default.
- Q92997836 P2093 Q92997836-B57B687C-EB90-4307-A0C9-57C831A08BE9 @default.
- Q92997836 P2093 Q92997836-BB30CF30-B5E4-488E-94F9-1C232998146B @default.
- Q92997836 P304 Q92997836-46DA4526-47B7-4B57-972E-E1C155936224 @default.
- Q92997836 P31 Q92997836-E3035FEC-126D-4515-9356-EF755D81BDE4 @default.
- Q92997836 P356 Q92997836-CCCC756F-8B0B-4397-9C52-2A35B28B50AB @default.
- Q92997836 P433 Q92997836-B3530F13-34EC-4558-908F-E7AC82C0718F @default.
- Q92997836 P478 Q92997836-83763C76-41F1-4F9E-B1B1-4C2448F24F89 @default.
- Q92997836 P50 Q92997836-5F6C4822-783A-45F6-91A2-A8E7D3FE8502 @default.
- Q92997836 P50 Q92997836-ACD1FE78-8C2B-4271-A9B9-AEDF2E1300F7 @default.
- Q92997836 P50 Q92997836-D465A199-765C-4104-83BD-A3C87CC46FEF @default.
- Q92997836 P577 Q92997836-E3F7E784-92EF-49F3-94E3-2C2828F31D6E @default.
- Q92997836 P698 Q92997836-D23C8A8A-C28A-4573-A99C-577620DA7B82 @default.
- Q92997836 P356 EIJ-D-18-01214 @default.
- Q92997836 P698 31235458 @default.
- Q92997836 P1433 Q26842537 @default.
- Q92997836 P1476 "BIOFLOW-IV, a randomised, intercontinental, multicentre study to assess the safety and effectiveness of the Orsiro sirolimus-eluting stent in the treatment of subjects with de novo coronary artery lesions: primary outcome target vessel failure at 12 months" @default.
- Q92997836 P2093 "Akihiko Takahashi" @default.
- Q92997836 P2093 "Bernhard Witzenbichler" @default.
- Q92997836 P2093 "Masaaki Uematsu" @default.
- Q92997836 P2093 "Michael Haude" @default.
- Q92997836 P2093 "Monica Masotti" @default.
- Q92997836 P2093 "Ralph Toelg" @default.
- Q92997836 P2093 "Ruiz Salmeron" @default.
- Q92997836 P2093 "Ton Slagboom" @default.
- Q92997836 P304 "e1006-e1013" @default.
- Q92997836 P31 Q13442814 @default.
- Q92997836 P356 "10.4244/EIJ-D-18-01214" @default.
- Q92997836 P433 "11" @default.
- Q92997836 P478 "15" @default.
- Q92997836 P50 Q56255586 @default.
- Q92997836 P50 Q7364511 @default.
- Q92997836 P50 Q89874771 @default.
- Q92997836 P577 "2019-12-06T00:00:00Z" @default.
- Q92997836 P698 "31235458" @default.